Philippines Grapples with Trust in Medical Innovation After Dengvaxia Controversy

An opinion piece explores the challenge of restoring public trust in medical innovation in the Philippines, particularly concerning new therapies like Daraxonrasib for pancreatic cancer, in the wake of the Dengvaxia controversy.